Company / Accounts Receivable
Schrödinger, Inc. Accounts Receivable History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$83.0M
FY2025
5-year range
$31.7M / $235.7M
FY2021-FY2025
Trend
-64.8%
vs FY2024
Sector context
#101 of 138
Health Care
What the data says
At $83M, Schrödinger, Inc.'s accounts receivable ranks #101 of 138 in the Health Care sector. Improved from $66M to $83M over the past 2 years.
Based on SEC 10-K filings.
$83M in FY2025 with a 5-year CAGR of +21.5%.
Improved from $66M to $83M over the past 2 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +14.1%
- 5-Year CAGR
- +21.5%
- 10-Year CAGR
- -
Sector benchmark
#101 of 138 in Health CareTop 73% of 138This company $83.0M Sector average $1.3B
▼
-93.7% below sector average
Key checks
Key Insights
- 5-year CAGR of +21.5%, indicating consistent growth.
- In FY2025, accounts receivable decreased 64.8% year-over-year.
- Ranks #101 out of 138 companies in the Health Care sector.
- Peak accounts receivable was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $83.0M | -64.8% |
| FY2024 | $235.7M | +257.2% |
| FY2023 | $66.0M | +17.9% |
| FY2022 | $56.0M | +76.3% |
| FY2021 | $31.7M | +1.0% |
| FY2020 | $31.4M | +68.3% |
| FY2019 | $18.7M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026